期刊文献+

小柴胡汤对食管癌化疗增敏及免疫耐受的逆转作用 被引量:12

Clinical observation of treatment and immune tolerance reversion in esophageal squamous carcinoma patients with XiaoChaiHu decoction combined chemotherapy
原文传递
导出
摘要 [目的]观察小柴胡汤联合紫杉醇加顺铂(TP)方案对晚期食管癌患者的疗效以及对免疫功能的影响并探讨其相关机制。[方法]晚期食管癌患者150例,随机分为对照组(75例)和观察组(75例),对照组仅予TP方案静脉化疗,观察组在化疗基础上口服小柴胡汤,21d为1周期,2周期后评估疗效及不良反应事件。采用流式细胞术检测患者化疗前后免疫功能评估免疫激活及免疫耐受状态。[结果]与对照组相比,观察组的有效率和控制率都有显著提高(P<0.05)。主要不良反应为中性粒细胞减少及消化道反应,观察组发生率明显减少(均P<0.05)。与化疗前相比,2组的免疫功能均有所恢复,观察组联合化疗后T细胞总数及亚群的逆转幅度更为明显,且差异有统计学意义(P<0.05)。[结论]小柴胡汤联合TP方案可提高化疗有效率、减少不良反应发生,其机制很可能是小柴胡汤通过逆转外周血中免疫耐受,激活免疫应答发挥的作用。 [Objective]To observe the effect of XiaoChaiHu Decoction combined TP(paclitaxel+cisplatin)chemotherapy regime in advanced esophageal squamous carcinoma patients,and investigate its mechanism of Immune function.[Methods]150 advanced esophageal squamous carcinoma patients were randomly divided into two groups,the control group(75 cases)which were treated with TP chemotherapy;and treatment groups(75 cases)which were treated with XiaoChaiHu Decoction combined the same chemotherapy.Both are 3 weeks for a course.After 2 courses,effectiveness and adverse effects were evaluated.Immune function was detected by Flow cytometer to assess immune response and tolerance.[Results]Effective rate and improvement of treatment group were higher than control group(P0.05).Adverse events of granulocytopenia and gastrointestinal reaction were fewer in treatment group(P0.05 respectively).After treatment,immune function was improved in both groups.The increase of total T cell and subgroup in treatment group were more obvious(P0.05).[Conclusion]The regime of XiaoChaiHu Decoction combined TP chemotherapy can improve efficacy,reduce adverse reaction that may be result from reversing immune tolerance and stimulating immune response.
作者 李燕 刘怀民 彭亮 张丽红 付槟梵 LI Yan;LIU Huai-min;PENG Liang;ZHANG Li-hong;FU Bin-fan(Department of Integrated Chinese and Western Medicine,The Affiliated Cancer Hospital of Zhengzhou University,Zhengzhou 450000,China;Department of Cardiovascular,Fuwai Central China Cardiovascular Hospital,Zhengzhou 450000,China)
出处 《中国中西医结合消化杂志》 CAS 2018年第7期579-581,585,共4页 Chinese Journal of Integrated Traditional and Western Medicine on Digestion
基金 河南省科技厅重点科技攻关项目(No:152102310155)
关键词 小柴胡汤 食管癌 化疗增敏 免疫耐受 XiaoChaiHu Decoction esophageal carcinoma chemotherapy enhancement response immune tolerance
  • 相关文献

参考文献5

二级参考文献27

  • 1Ze-Tian Shen,Xin-Hu Wu,Bing Li,Jun-Shu Shen,Zhen Wang,Jing Li,Xi-Xu Zhu.Nedaplatin concurrent with three-dimensional conformal radiotherapy for treatment of locally advanced esophageal carcinoma[J].World Journal of Gastroenterology,2013,19(48):9447-9452. 被引量:23
  • 2崔清,金长娟,李蕾,郭毅峻.中西药综合治疗食管癌术后患者的临床观察[J].现代中西医结合杂志,2006,15(3):307-308. 被引量:7
  • 3Ke X,Wang J,Li L,et al.Roles of CD4+CD25high FOXP3+ Tregs in lymphomas and tumors are complex[J].Front Bio Sci,2008,13:3986-4001. 被引量:1
  • 4Jiang S,Lechler RI.CD4+CD25+ regulatory T-cell therapy for allergy,autoimmune disease and transplant rejection[J].Inflamm Allergy Drug Targets,2006,5(4):239-242. 被引量:1
  • 5Fu J,Xu D,Liu Z,et al.Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients[J].Gastroenterology,2007,132(7):2328-2339. 被引量:1
  • 6Ghiringhelli F,Menard C,Terme M,et al.CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner[J].J Exper Med,2005,202(8):1075-1085. 被引量:1
  • 7Pandiyan P,Zheng L,Ishihara S,et al.CD4+CD25+FOXP3+ regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4+ T cells[J].Nat Immunol,2007,8(12):1353-1362. 被引量:1
  • 8Sharma S,Yang SC,Zhu L,et al.Tumor cyclooxygenase-2/prostaglandin E2-dependent promotion of FOXP3 expression and CD4+ CD25+ T regulatory cell activities in lung cancer[J].Cancer Research,2005,65(12):5211-5220. 被引量:1
  • 9Valzasina B,Piconese S,Guiducci C,et al.Tumor-induced expansion of regulatory T cells by conversion of CD4+CD25-lymphocytes is thymus and proliferation independent[J].Cancer Research,2006,66(8):4488-4495. 被引量:1
  • 10柯琴.伤寒来苏集.北京:学苑出版社,2009:352. 被引量:3

共引文献52

同被引文献387

引证文献12

二级引证文献72

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部